| 000 | 01582 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517060905.0 | ||
| 264 | 0 | _c20170103 | |
| 008 | 201701s 0 0 eng d | ||
| 022 | _a1873-6513 | ||
| 024 | 7 |
_a10.1016/j.jpainsymman.2015.09.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlawneh, Alia | |
| 245 | 0 | 0 |
_aClinical Factors Associated With a Short Survival Time After Percutaneous Nephrostomy for Ureteric Obstruction in Cancer Patients: An Updated Model. _h[electronic resource] |
| 260 |
_bJournal of pain and symptom management _cFeb 2016 |
||
| 300 |
_a255-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Validation Study | ||
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 |
_aNephrostomy, Percutaneous _xstatistics & numerical data |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aSerum Albumin _xmetabolism |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aUreteral Obstruction _xcomplications |
| 700 | 1 | _aTuqan, Wa'el | |
| 700 | 1 | _aInnabi, Ayoub | |
| 700 | 1 | _aAl-Nimer, Yanal | |
| 700 | 1 | _aAzzouqah, Ola | |
| 700 | 1 | _aRimawi, Dalia | |
| 700 | 1 | _aTaqash, Ayat | |
| 700 | 1 | _aElkhatib, Maan | |
| 700 | 1 | _aKlepstad, Pål | |
| 773 | 0 |
_tJournal of pain and symptom management _gvol. 51 _gno. 2 _gp. 255-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpainsymman.2015.09.009 _zAvailable from publisher's website |
| 999 |
_c25384006 _d25384006 |
||